(09-08-2018, 07:28 PM)Mystic Wanderer Wrote: Are "they" trying to justify this before their evil acts become public?
Quote:This start-up is offering $8,000 blood transfusions from teens to people who want to fight aging.CNBC:
'It might sound like science fiction, or a recent episode of "Silicon Valley," but a start-up called
Ambrosia is charging $8,000 for blood transfusions from young people.
About 100 people have signed up to receive an infusion, founder Dr. Jesse Karmazin said
Wednesday at the Code Conference. Anyone over age 35 can become an Ambrosia customer,
said Karmazin, but most of the early adopters tend to be of retirement age.
He also stressed that it's a range of people, and not just Bay Area technologists, who have
signed up.
The donated blood typically comes from teenagers, although anyone under age 25 is eligible.
The company buys its supply from blood banks, which also sell blood to pharmaceutical
companies. So high-schoolers donating their blood are not aware that it might be used on
healthy adults.
Speaking to a roomful of technologists, Karmazin explained that the company does not claim
that it can cure aging. Instead, he's hoping to recruit hundreds more people to research whether
the transfusions can help fight particular symptoms associated with aging.
Traditionally, biological aging hasn't been treated as a disease, which makes it challenging to
study. Karmazin said those who have signed up have seen some positive benefits and haven't
reported any negative ones. Blood transfusions come with a variety of risks, including allergic
reactions.
Karmazin started the company after reviewing research into whether injecting older mice with
the plasma portion of young ones can improve memory. Other so-called parabiosis studies
went a step further in connecting older and younger animals so that their blood mingles.
These studies are far from definitive, and scientists have spoken out about the ethics of such
a study, which they see as taking advantage of the public's excitement and lacking much
evidence. But the concept has seen a recent resurgence in interest because well-known
Silicon Valley investors like Peter Thiel have spoken out about its promise.
But that does not mean Thiel gets teenage blood transfusions, said Karmazin, a graduate of
Stanford Medical School. Karmazin stressed that Thiel is not an Ambrosia customer -and to
his knowledge, Ambrosia is the only U.S. company on the market.
"Of course, it's possible he could have gone abroad," Karmazin shrugged.
"But I haven't heard anything about that."
Thiel didn't immediately reply to a CNBC request for comment...'
Which explains Henry Kissinger... and people mock 'Pizzagate'.
Sky News put a different slant on it...
Quote:'...Dame Linda Partridge, a geneticist at UCL, said research shows that young blood could allowSKY News:
humans to live a life free of diseases such as cancer and heart disease right up until their deaths.
"I would say ageing is the emperor of all diseases," she told The Times.
"A lot of people regard ageing as 'natural' and that therefore you shouldn't interfere with nature.
But we've always considered it an ethical imperative to cure illness where we find it."
Professor Partridge's analysis of data forms are part of a wave of studies and trials backed by
PayPal co-founder Peter Thiel at a San Francisco start-up called Ambrosia.
The trials saw older adults injected with young blood - something that would cost around $8,000
(£6,200) if rolled out to the public...'
Edith Head Gives Good Wardrobe.